Literature DB >> 29317761

MK2 puts an additional brake on RIPK1 cytotoxic potential.

Yves Dondelinger1,2, Tom Delanghe1,2, Mathieu M J Bertrand3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29317761      PMCID： PMC5864190          DOI： 10.1038/s41418-017-0009-z

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  15 in total

1.  NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling.

Authors:  Yves Dondelinger; Sandrine Jouan-Lanhouet; Tatyana Divert; Emilie Theatre; John Bertin; Peter J Gough; Piero Giansanti; Albert J R Heck; Emmanuel Dejardin; Peter Vandenabeele; Mathieu J M Bertrand
Journal:  Mol Cell       Date:  2015-09-03       Impact factor: 17.970

Review 2.  Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.

Authors:  Michael Croft; Richard M Siegel
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

3.  Quantitative Phospho-proteomic Analysis of TNFα/NFκB Signaling Reveals a Role for RIPK1 Phosphorylation in Suppressing Necrotic Cell Death.

Authors:  Firaz Mohideen; Joao A Paulo; Alban Ordureau; Steve P Gygi; J Wade Harper
Journal:  Mol Cell Proteomics       Date:  2017-05-24       Impact factor: 5.911

4.  p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection.

Authors:  Manoj B Menon; Julia Gropengießer; Jessica Fischer; Lena Novikova; Anne Deuretzbacher; Juri Lafera; Hanna Schimmeck; Nicole Czymmeck; Natalia Ronkina; Alexey Kotlyarov; Martin Aepfelbacher; Matthias Gaestel; Klaus Ruckdeschel
Journal:  Nat Cell Biol       Date:  2017-09-18       Impact factor: 28.824

5.  Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis.

Authors:  Rei Kawashima; Yuki I Kawamura; Tomoyuki Oshio; Aoi Son; Motomi Yamazaki; Teruki Hagiwara; Toshihiko Okada; Kyoko Inagaki-Ohara; Ping Wu; Suzanne Szak; Yutaka J Kawamura; Fumio Konishi; Oki Miyake; Hideaki Yano; Yukio Saito; Linda C Burkly; Taeko Dohi
Journal:  Gastroenterology       Date:  2011-09-03       Impact factor: 22.682

6.  RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.

Authors:  Y Dondelinger; M A Aguileta; V Goossens; C Dubuisson; S Grootjans; E Dejardin; P Vandenabeele; M J M Bertrand
Journal:  Cell Death Differ       Date:  2013-07-26       Impact factor: 15.828

Review 7.  Necroptosis.

Authors:  Andreas Linkermann; Douglas R Green
Journal:  N Engl J Med       Date:  2014-01-30       Impact factor: 91.245

Review 8.  More to Life than NF-κB in TNFR1 Signaling.

Authors:  Adrian T Ting; Mathieu J M Bertrand
Journal:  Trends Immunol       Date:  2016-07-13       Impact factor: 16.687

9.  NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-κB-Dependent and -Independent Functions.

Authors:  Katerina Vlantis; Andy Wullaert; Apostolos Polykratis; Vangelis Kondylis; Marius Dannappel; Robin Schwarzer; Patrick Welz; Teresa Corona; Henning Walczak; Falk Weih; Ulf Klein; Michelle Kelliher; Manolis Pasparakis
Journal:  Immunity       Date:  2016-03-15       Impact factor: 31.745

10.  Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis.

Authors:  Jiefei Geng; Yasushi Ito; Linyu Shi; Palak Amin; Jiachen Chu; Amanda Tomie Ouchida; Adnan Kasim Mookhtiar; Heng Zhao; Daichao Xu; Bing Shan; Ayaz Najafov; Guangping Gao; Shizuo Akira; Junying Yuan
Journal:  Nat Commun       Date:  2017-08-25       Impact factor: 14.919
View more
  3 in total

Review 1.  The resurrection of RIP kinase 1 as an early cell death checkpoint regulator-a potential target for therapy in the necroptosis era.

Authors:  Eunjin Ju; Kyeong Ah Park; Han-Ming Shen; Gang Min Hur
Journal:  Exp Mol Med       Date:  2022-09-28       Impact factor: 12.153

2.  Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation.

Authors:  Yves Dondelinger; Tom Delanghe; Dario Priem; Meghan A Wynosky-Dolfi; Daniel Sorobetea; Diego Rojas-Rivera; Piero Giansanti; Ria Roelandt; Julia Gropengiesser; Klaus Ruckdeschel; Savvas N Savvides; Albert J R Heck; Peter Vandenabeele; Igor E Brodsky; Mathieu J M Bertrand
Journal:  Nat Commun       Date:  2019-04-15       Impact factor: 14.919

3.  RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcoma.

Authors:  Henry G Smith; Kunzah Jamal; Kevin J Harrington; Pascal Meier; Jasbani Hs Dayal; Tencho Tenev; Joan Kyula-Currie; Naomi Guppy; Patrycja Gazinska; Victoria Roulstone; Gianmaria Liccardi; Emma Davies; Ioannis Roxanis; Alan A Melcher; Andrew J Hayes; Gareth J Inman
Journal:  EMBO Mol Med       Date:  2020-05-18       Impact factor: 12.137
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.